CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 105 enrolled
Drug / intervention
Tumor markersother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01699698
NCT01699698N/ACompleted
CompareCT.gov

Pancreatic Juice Diagnosis From Duodenum

Olympus Corporation·interventional·Posted Oct 4, 2012·Updated Sep 21, 2015

In Brief

A clinical study evaluating Tumor markers for Pancreatic Adenocarcinoma. Completed, enrolled 105 participants across 2 sites in 2 countries.

Detailed Summary

Purpose of this study is to understand the clinical feasibility of duodenal juice diagnosis to screen UICC stage II pancreatic ductal adenocarcinoma patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Adenocarcinoma
CountriesJapan, United States
CollaboratorsMayo Clinic, Kyushu University, The University of Texas Health Science Center, Houston

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 4, 2012
Enrollment StartOct 1, 2012
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.7 years ago

Interventions

Tumor markersother

Duodenal juice are collected using endoscope and cannula. Tumor markers of collected samples are analyzed. The marker concentration is applied to statistical analysis.